Nanocarrier-based approaches to combat chronic obstructive pulmonary disease

Area of Science:

• Pulmonary Medicine
• Nanotechnology
• Pharmacotherapy

Background:

• Airway mucus abnormalities cause pulmonary disorders like asthma, fibrosis, and COPD.
• COPD is a globally prevalent chronic respiratory disease.
• Conventional COPD treatments struggle with effective drug delivery to target sites.

Purpose of the Study:

• To review current COPD treatments.
• To highlight nanocarrier-based approaches for enhanced drug delivery in COPD.
• To explore the potential of gene and stem cell therapies for COPD.

Main Methods:

• Literature review of nanocarrier applications in COPD.
• Analysis of drug delivery challenges in conventional COPD therapies.
• Exploration of emerging therapeutic strategies including gene and stem cell therapy.

Main Results:

• Nanocarriers offer sustained release, improved targeting, and better patient compliance for COPD pharmacotherapy.
• Nanocarrier systems overcome airway defenses, enhancing therapeutic efficacy.
• Gene and stem cell therapies show promise as advanced treatment modalities for COPD.

Conclusions:

• Nanocarrier-based strategies represent a significant advancement in COPD treatment by improving drug delivery and efficacy.
• Emerging therapies like gene and stem cell therapy hold potential for future COPD management.
• Further research into these advanced approaches is crucial for combating COPD effectively.